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Background: The World Health Organization has estab-
lished a worldwide program for gonococcal antimicrobial sur-
veillance, but so far no data on gonococcal susceptibility in
Central Asia are available.
Goal: The need for biological data on the susceptibility of
Neisseria gonorrhoeae in Kyrghyzstan, to enable adaptation of
the national treatment protocol for gonococcal infections, led
Me ´decins Sans Frontie `res and Epicentre to conduct a survey in
collaboration with the Alfred Fournier Institute in Paris and
the health authorities in Bishkek.
Study Design: In vitro susceptibility of N gonorrhoeae
strains was determined with use of the reference agar-plate
dilution technique.
Results: Results for 11 antibiotics tested on 120 strains of
gonococci showed a low proportion (11.7%) of penicillinase-
producing N gonorrhoeae and high proportions of intermedi-
ate or resistant strains to the majority of the antibiotics tested,
including ﬂuoroquinolones (>25% of strains resistant). All the
strains were susceptible to spectinomycin, and only two strains
had decreased susceptibility to ceﬁxime.
Conclusion: The therapeutic choices available in
Kyrghyzstan appear to be limited to cephalosporins and
spectinomycin.
AN ESTIMATED 333 MILLION adult cases of curable
sexually transmitted infections (STIs; gonorrhea, chla-
mydia, syphilis, and trichomoniasis) occurred worldwide in
1995, including 18 million in Central Asia and Eastern
Europe, where STIs are a major public health problem.1 The
situation is complicated by the decreasing susceptibility of
the germs (in particular, Neisseria gonorrhoeae) to com-
monly used antibiotics, especially the penicillin group. The
World Health Organization therefore established in 1990 a
surveillance program in nine regions of the world (the
Gonococcal Antimicrobial Surveillance Program, or
GASP), but so far no data on gonococcal susceptibility in
Central Asia are available.
Since 1996, Me ´decins Sans Frontie `res has been running a
control program for STIs in the Osh region, in the southeast
of Kyrghyzstan. In accordance with the World Health Or-
ganization standards, Me ´decins Sans Frontie `res recom-
mends kanamycin or cotrimoxazole for the treatment of
gonococcal infections, although these drugs should be used
only in regions where they show continuing efﬁcacy.2 The
national protocol in Kyrghyzstan recommends penicillin as
ﬁrst-line therapy, but in practice several antibiotics are used,
including kanamycin at high doses (10 g intramuscularly).
A study was conducted within the Me ´decins Sans Fron-
tie `res program between January 1999 and April 2000, in
collaboration with the Kyrghyz health authorities, espe-
cially the Dermato-Venerological Republican Center, lo-
cated in the capital (Bishkek), and the Alfred Fournier
Institute in Paris. Its objective was to determine the in vitro
susceptibility of N gonorrhoeae.
Materials and Methods
Subjects included in the study were all male patients
presenting with simple acute purulent urethritis. They were
all given free treatment with cotrimoxazole or kanamycin,
as part of the standard regimen of the World Health
Organization.
It is estimated that 100 to 150 gonococcal isolates need to
be collected to measure a signiﬁcant shift in antibiotic
resistance between two surveys.3 It was therefore necessary
to include a total of 170 patients, with an expected loss of
40% of strains after thawing.
The Neisseria identiﬁcation was ﬁrst suspected by direct
examination of strains (during which intracellular diplo-
cocci were noted) and Gram staining (negative), and it was
conﬁrmed by cultures of isolates that were under suspicion
after Gram staining and oxidase testing (oxidase-positive).
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376Several culture media were tested (with addition of glucose,
hemoglobin, horse blood, and human blood), on Thayer–
Martin medium. Cultures were performed with and without
antibiotics, because a proportion of 0.3% to 30.0% of gono-
coccal strains are naturally resistant to vancomycin.4 Be-
cause of the urogenital origin of samples, carbohydrate
degradation tests, which identify the type of Neisseria, were
not performed, and positive cultures were assumed to be N
gonorrhoeae. The MIC was determined by means of the
reference agar-plate dilution technique, with chocolate agar
in tryptic soy broth (Oxoid, Basingstoke, U.K.) supple-
mented with 5% horse cooked blood and 1% IsoVitaleX.3
For cotrimoxazole, the medium used was the World Health
Organization–recommended diagnostic susceptibility test-
ing agar, with lysed horse blood and Kellogg’s supplement.5
Plasmid-mediated antimicrobial resistance (-lactamase)
was ﬁrst detected in Kyrghyzstan by the chromogenic
method and was conﬁrmed at the Alfred Fournier Institute
by the acidimetric method.
The susceptibility of the N gonorrhoeae isolates was
tested against 11 antibiotics: penicillin G (Diamant), ce-
ﬁxime (Rho ˆne-Poulenc), tetracycline (Roussel–Uclaf), cip-
roﬂoxacin (Bayer), ceftriaxone, spectinomycin, kanamycin,
oﬂoxacin, chloramphenicol, trimethoprim/sulfamethoxazole
(TMP/SMZ), and erythromycin (Sigma). The strains were
considered to be susceptible, intermediate, or resistant ac-
cording to the interpretative standards and breakpoints de-
ﬁned by the National Committee for Clinical Laboratory
Standards for aerobic bacteria, and the ﬁndings are included
in Table 1.5 For ceﬁxime, we used the Antibiogramme
Committee of the French Society for Microbiology refer-
ence values.6 Three control/reference strains (Canadian or-
igin; LSPQ 2664, 2667, and 2668) were included in the
MIC study. The ﬁnal bacterial inoculum was of 10
4 to 10
5
cfu/ml.
The development of gonococcal resistance to antibiotics
may involve either chromosomal or extrachromosomal
(plasmid) mechanisms, and for some antibiotics both may
be implicated. Chromosomally mediated resistance is gen-
erally low (especially against penicillin and tetracycline)
and results from modiﬁcations in the outer cell membrane
and changes in access of the antibiotic to this target site. In
addition, gonococcal acquisition of one of several types of
plasmid results in high-level resistance to antibiotics.7
The strains were kept in a nutrition broth with 10%
glycerol and frozen in liquid nitrogen. They were trans-
ported to France on dry ice and kept at the Alfred Fournier
Institute at 80 °C.
Since Kyrghyzstan has no ethics committee, the protocol
was submitted to a French ethics committee, according to
CIOMS recommendations.8 Informed written consent was
obtained from patients.
Results
A total of 189 patients were included between January 20
and April 21, 1999, of whom 168 (89%) had a positive
culture for N gonorrhoeae. The age of patients ranged from
13 to 60 years (median, 24 years). Associated Trichomonas
was found in 42.9% (72/168).
The medium that produced the “best” cultures (number of
strains and legibility) and therefore the most identiﬁable
strains was Thayer–Martin, with supplements I and II and
fresh human blood.
Four strains4 were lost in Kyrghyzstan, but 164 were sent
to France, of which 142 have been reinoculated so far; only
7 (5%) did not grow after thawing. MIC determinations
were made for the ﬁrst 120 strains (Table 1).
Among the strains resistant to penicillin, 17 (14.2%)
showed a low-level/chromosomic resistance, and 14
(11.7%) were penicillinase-producing N gonorrhoeae,a s
evidence by the acidimetric method, with high-level/plas-
midic resistance (MIC, 32.0 mg/l). All strains resistant to
tetracycline had low-level/chromosomic resistance (MIC,
16.0 mg/l), and for none was the MIC 16.0 mg/l, cor-
responding to a high-level resistance in relation to the
TABLE 1. Susceptibility of 120 Strains of Neisseria gonorrhoeae Isolated in Kyrghyzstan Between January and April 1999
Antibiotic
MIC Reference
Values, mg/l
Susceptibility Proﬁle  No. (%) of Isolates
Susceptible Intermediate Resistant
Penicillin G 0.06–2.0 13 (10.8) 76 (63.3) 31 (25.9)
Tetracycline 0.5–2.0 39 (32.5) 42 (35.0) 39 (32.5)
Erythromycin 1.0–4.0 63 (52.5) 53 (44.2) 4 (3.3)
Chloramphenicol 0.5–2.0 6 (5.0) 52 (43.3) 62 (51.7)
Ceftriaxone 0.25 120 (100.0) 0 (0.0) 0 (0.0)
Ceﬁxime 1.0 118 (98.3) 2 (1.7) 0 (0.0)
Spectinomycin 32.0–128.0 120 (100.0) 0 (0.0) 0 (0.0)
Kanamycin 32.0–128.0 82 (68.3) 33 (27.5) 5 (4.2)
TMP/SMZ 0.5/9.5–4.0/76.0 5 (4.2) 113 (94.1) 2 (1.7)
Ciproﬂoxacin 0.125–1.0 80 (66.7) 28 (23.3) 12 (10.0)
Oﬂoxacin 0.5–2.0 79 (65.8) 23 (19.2) 18 (15.0)
TMP/SMZ  trimethoprim/sulfamethoxazole.
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(11.7% of the sample) were resistant to both penicillin and
tetracycline.
Two strains2 were intermediate for ceﬁxime (MICs, 2.0
and 4.0 mg/l) and had decreased susceptibility to ceftriax-
one (MIC, 0.125 mg/l) but were not penicillinase-produc-
ing. With 100% of strains susceptible to spectinomycin, this
antibiotic had a better efﬁcacy than kanamycin, to which 38
(31.7%) were intermediate or resistant.
Among the 30 and 32 strains exhibiting decreased sus-
ceptibility to ciproﬂoxacin and oﬂoxacin, respectively, the
MICs for 9 (7.5%) and 18 (15.0%) were quite elevated
(1.0 mg/l); for 9 of them, the MICs of both antibiotics
were elevated.
Discussion
Our study revealed a high proportion of gonococcal re-
sistance to several antibiotics in our setting. Although de-
creased susceptibility to an antibiotic can be countered in
the early stages with increased dosages (as for kanamycin in
Kyrghyzstan), resistance to this antibiotic is expected to
occur shortly afterward, therefore preventing its
recommendation.
The proportion of penicillinase-producing N gonorrhoeae
(11.7%, which is relatively low in comparison with that in
other Asian countries9) is similar to that in France10 and
might be attributed to the limited use of penicillin in
Kyrghyzstan over the past few years. The association of
chromosomic resistance between penicillin and tetracycline
(11.7% of the strains in this study) is frequent and has been
described worldwide.11
The high proportion of strains intermediate or resistant to
chloramphenicol might be the consequence of excessive
utilization of this antibiotic for other pathologic conditions,
because it is frequently observed in developing countries.
Natural resistance of gonococci to trimethoprim, com-
bined with a high proportion of resistance to sulfonamides,
might explain the low activity of TMP-SMZ on N gonor-
rhoeae. Since TMP-SMZ is no longer used for the treatment
of gonococcal infections, except in developing countries, no
data on the susceptibility of strains are available so far.
The high proportion of strains (25.0%) exhibiting de-
creased susceptibility to ﬂuoroquinolones is similar to that
observed in Asia and Southeast Asia9 and much higher than
that observed in Europe, especially in France, where it is
3%.10
The very low proportion of strains (5%) that did not grow
after thawing indicates that the procedures implemented for
the conservation and the transport of the strains were ade-
quate. However, the frequent polycontamination of the
strains with other pathogens (Staphylococcus) observed at
the Alfred Fournier Institute is probably due to a lack of
asepsis in the laboratory procedures.
Although our results should be conﬁrmed through other
drug susceptibility studies conducted in different settings,
they clearly indicate a reduction of the therapeutic alterna-
tives for treating gonococcal STIs in Kyrghyzstan to third-
generation cephalosporins and spectinomycin. In addition,
further studies about mechanisms of resistance, especially
to ﬂuoroquinolones, should be conducted.
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